Catalyst Pharmaceuticals Inc (CPRX)
- Exchange
- NASDAQ
- Symbol
- CPRX
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, neuromuscular, and chronic neurological diseases in the United States. The company is headquartered in Coral Gables, Florida.
- Country
- USA
Stock price
At close: November 5, 2024
-
Open21.57
-
High22.05
-
Low21.41
-
Close21.96
-
Volume872,619
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
12.87
Receivables turnover
7.44
Payables turnover
13.60
Working capital turnover
2.78
Days of inventory on hand (DOH)
28.37
Days of sales outstanding (DSO)
49.05
Number of days of payables
26.83
Fixed asset turnover
333.23
Total asset turnover
0.85
Current ratio
2.88
Quick ratio
2.51
Cash ratio
1.81
Cash conversion cycle
50.59
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.21
Interest coverage
—
Gross profit margin
49.46%
Operating profit margin
21.80%
Pretax margin
23.73%
Net profit margin
17.93%
Operating return on assets (Operating ROA)
18.47%
Return on assets (ROA)
15.19%
Return on total capital
22.38%
Return on equity (ROE)
18.41%